• Front Page News
  • About
    ▼
    • Our mission
    • J D Faccinetti
    • Lewis S Blevins Jr., MD
    • Press
    • Terms and conditions
    • Our Sponsors
    • Sponsorship information
  • News & Blog
    ▼
    • Front Page News
    • Featured
    • News From ‘Round the World
    • Advocacy Zone
    • Patients’ Corner
    • For Professionals
    • Dr. Blevins Corner
    • Briefings
    • Industry News
  • Media & Resources
    ▼
    • Podcasts
    • Live Talk On Demand
    • Educational Video Presentations
    • Videos
    • Mental and Emotional Health
    • Musings
    • Health and Fitness
    • Downloads
    • Resources
  • Podcasts
  • Pituitary Diseases
    ▼
    • Acromegaly
    • Cushing’s
    • Growth Hormone Deficiency
    • Diabetes Insipidus
    • Hypopituitarism
    • Prolactinoma
    • Other Pituitary Tumors
  • Treatment News & Info
    ▼
    • Clinical Trials
    • Health and Fitness
    • Mental and Emotional Health
Skip to content

Main Navigation

pwn-logo
  • About
    • Our mission
    • J D Faccinetti
    • Lewis S Blevins Jr., MD
    • Press
    • Terms and conditions
    • Our Sponsors
    • Sponsorship information
    • Contact Us
  • News & Media
      • News & Media

        Get the latest news from Pituitary World News, a non-profit organization that seeks to increase awareness and reduce the number of undiagnosed and misdiagnosed people with a debilitating pituitary disease. PWN publishes regular blog posts and podcasts on pituitary diseases and treatments with the world's leading experts.

      • News & Blog


      • Front Page News
      • Featured
      • News From ‘Round the World
      • Advocacy Zone
      • Patients’ Corner
      • For Professionals
      • Dr. Blevins Corner
      • Briefings
      • Industry News
      • Media & Resources


      • Podcasts
      • Live Talk On Demand
      • Educational Video Presentations
      • Videos
      • Mental and Emotional Health
      • Musings
      • Health and Fitness
      • Download Materials
      • Resources
  • Podcasts
  • Disease & Treatment
      • Disease & Treatment

        Information, news, resources and insights from the world's leading experts on specific pituitary conditions and treatments, including research and clinical trials.

      • Pituitary Diseases


      • Acromegaly
      • Cushing’s
      • Growth Hormone Deficiency
      • Diabetes Insipidus
      • Hypopituitarism
      • Prolactinoma
      • Other Pituitary Tumors
      • Treatment News & Info


      • Clinical Trials
      • Health and Fitness
      • Mental and Emotional Health
  • Subscribe
  • Donate
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Industry News

News from pharmaceutical companies and other related healthcare organizations

Subscribe to PWN and get the latest posts in your inbox

Recordati Rare Diseases provides access to the LINC 4 study in the Journal of Clinical Endocrinology and Metabolism (JCEM).

June 22, 2022
Cushing's|Industry News|

This study is available free. Just click on this link to download it. As a way of background, this is the second Phase 3 study for ISTURISA (osilodrostat). The first phase 3 study, LINC 3,

A new drug for Cushing’s: Learn more

April 22, 2020
Cushing's|Industry News|Patients' Corner|

In this podcast, Dr. Lewis Blevins discusses a new drug for Cushing’s disease recently approved in the US.  

Exciting news for acromegaly and NET’s from Crinetics Pharmaceuticals!

April 9, 2020
Industry News|News From 'Round the World|

In a press release today, San Diego, California based Crinetics Pharmaceuticals reports positive results from their Phase Two trial of PALTUSOTINE (the former CRN00808). This is a new oral medication to treat acromegaly and neuroendocrine

News on Signifor, Signifor LAR, and newly approved Cushing’s drug ISTURISA

April 8, 2020
Industry News|News From 'Round the World|Patients' Corner|

Recordati Rare Diseases, Inc., based in Lebanon, NJ, has recently acquired the rights to SIGNIFOR® LAR and the FDA approval for ISTURISA®(osilodrostat). Both products treat pituitary diseases. SIGNIFOR LAR, a “2nd generation” somatostatin analog given

Questions about access to therapies, financial assistance?

March 30, 2020
Industry News|Patients' Corner|

If you are currently taking, or are about to start taking Lanreotide (Somatuline Depot) injections, this website from Ipsen offers a wealth of information about patient access to therapies.  IPSEN CARES serves as a central

Posts navigation

  • Previous
  • 1
  • 2

Stay Up to Date

Get notified whenever there is a new post from Pituitary World News.

Popular Categories

  • Patients’ Corner
  • Dr. Blevins Corner
  • Podcasts
  • News Feed
  • Advocacy Zone
  • News From ‘Round the World

Explore Topics

  • Acromegaly
  • Mental and Emotional Health
  • Cushing’s
  • Diabetes Insipidus
  • Growth Hormone Deficiency
  • Health and Fitness
  • Hypopituitarism
  • Prolactinoma

Our Mission

Pituitary World News is a non-profit organization that seeks to increase awareness and reduce the number of undiagnosed and misdiagnosed people with a debilitating pituitary disease. PWN’s sole reason for being is to help diagnose people properly and early by increasing awareness of pituitary disorders and providing a platform for communications, collaborations, creativity, and innovation.

Follow PWN

  • Facebook
  • Twitter
  • Terms of Use
  • Privacy
  • Cookie Policy
  • Accessibility
Copyright © 2022 Pituitary World News. All rights reserved.